BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 37671529)

  • 21. Evaluation of physical function and its association with body composition, quality of life and biomarkers in cancer cachexia patients.
    Anderson LJ; Lee J; Mallen MC; Migula D; Liu H; Wu PC; Dash A; Garcia JM
    Clin Nutr; 2021 Mar; 40(3):978-986. PubMed ID: 32713720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between muscle mass and function in cancer cachexia: smoke and mirrors?
    Ramage MI; Skipworth RJE
    Curr Opin Support Palliat Care; 2018 Dec; 12(4):439-444. PubMed ID: 30138131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the criteria for response to cachexia treatment?
    Crawford J
    Ann Palliat Med; 2019 Jan; 8(1):43-49. PubMed ID: 30685983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
    Mantovani G
    Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):292-301. PubMed ID: 20496538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinically Important Reductions in Physical Function and Quality of Life in Adults with Tumor Prostheses in the Hip and Knee: A Cross-sectional Study.
    Fernandes L; Holm CE; Villadsen A; Sørensen MS; Zebis MK; Petersen MM
    Clin Orthop Relat Res; 2021 Oct; 479(10):2306-2319. PubMed ID: 33974591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise interventions on health-related quality of life for people with cancer during active treatment.
    Mishra SI; Scherer RW; Snyder C; Geigle PM; Berlanstein DR; Topaloglu O
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD008465. PubMed ID: 22895974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome.
    Madeddu C; Dessì M; Panzone F; Serpe R; Antoni G; Cau MC; Montaldo L; Mela Q; Mura M; Astara G; Tanca FM; Macciò A; Mantovani G
    Clin Nutr; 2012 Apr; 31(2):176-82. PubMed ID: 22047681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia.
    Burney BO; Hayes TG; Smiechowska J; Cardwell G; Papusha V; Bhargava P; Konda B; Auchus RJ; Garcia JM
    J Clin Endocrinol Metab; 2012 May; 97(5):E700-9. PubMed ID: 22419719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
    Currow D; Temel JS; Abernethy A; Milanowski J; Friend J; Fearon KC
    Ann Oncol; 2017 Aug; 28(8):1949-1956. PubMed ID: 28472437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exercise interventions for adults with cancer receiving radiation therapy alone.
    Trommer M; Marnitz S; Skoetz N; Rupp R; Niels T; Morgenthaler J; Theurich S; von Bergwelt-Baildon M; Baues C; Baumann FT
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013448. PubMed ID: 36912791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
    Takayama K; Katakami N; Yokoyama T; Atagi S; Yoshimori K; Kagamu H; Saito H; Takiguchi Y; Aoe K; Koyama A; Komura N; Eguchi K
    Support Care Cancer; 2016 Aug; 24(8):3495-505. PubMed ID: 27005463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Objective Measurements of Physical Function to Predict Survival in Patients with Metastatic Cancer.
    Migdanis I; Gioulbasanis I; Migdanis A; Armeni E; Sgantzos M; Kapsoritakis A; Kontogianni MD
    Nutr Cancer; 2023; 75(3):912-922. PubMed ID: 36688336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise for improving outcomes after osteoporotic vertebral fracture.
    Gibbs JC; MacIntyre NJ; Ponzano M; Templeton JA; Thabane L; Papaioannou A; Giangregorio LM
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD008618. PubMed ID: 31273764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
    Katakami N; Uchino J; Yokoyama T; Naito T; Kondo M; Yamada K; Kitajima H; Yoshimori K; Sato K; Saito H; Aoe K; Tsuji T; Takiguchi Y; Takayama K; Komura N; Takiguchi T; Eguchi K
    Cancer; 2018 Feb; 124(3):606-616. PubMed ID: 29205286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of multimodal intervention care on cachexia in patients with advanced cancer compared to conventional management (MIRACLE): an open-label, parallel, randomized, phase 2 trial.
    Maeng CH; Kim BH; Chon J; Kang WS; Kang K; Woo M; Hong IK; Lee J; Lee KY
    Trials; 2022 Apr; 23(1):281. PubMed ID: 35410294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychosocial interventions for patients with head and neck cancer.
    Semple C; Parahoo K; Norman A; McCaughan E; Humphris G; Mills M
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009441. PubMed ID: 23857592
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.